|
|
Volumn 365, Issue 25, 2011, Pages 2432-2434
|
|
Lebrikizumab treatment in adults with asthma [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LEBRIKIZUMAB;
NITRIC OXIDE;
PLACEBO;
TRANSCRIPTION FACTOR RUNX2;
GLUCOCORTICOID;
INTERLEUKIN 13;
MONOCLONAL ANTIBODY;
ASTHMA;
EXHALATION;
FORCED EXPIRATORY VOLUME;
HUMAN;
LETTER;
LUNG FUNCTION;
PRIORITY JOURNAL;
TREATMENT DURATION;
TREATMENT RESPONSE;
ASTHMA CONTROL QUESTIONNAIRE 5;
OUTCOME ASSESSMENT;
PATIENT COMPLIANCE;
QUESTIONNAIRE;
DRUG ANTAGONISM;
FEMALE;
MALE;
NOTE;
ANTIBODIES, MONOCLONAL;
ASTHMA;
FEMALE;
HUMANS;
INTERLEUKIN-13;
MALE;
|
|
EID: 84855171665
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1112234 Document Type: Letter |
|
Times cited : (5)
|
|
References (1)
|
